Cellebrite DI (NASDAQ:CLBT) Trading Up 3% Following Earnings Beat

Key Points

• Cellebrite DI Ltd. shares rose by 3% after the company reported quarterly earnings of $0.12 per share, beating estimates of $0.11.
• The company's quarterly revenue increased by 18.4% compared to the same period last year, indicating growth despite a negative net margin of 46.34%.
• Wall Street analysts maintain a consensus price target of $22.43 for Cellebrite DI, with most analysts rating the stock as a "buy" or "hold."

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) shot up 3% on Thursday following a better than expected earnings announcement. The stock traded as high as $14.54 and last traded at $14.40. 973,332 shares were traded during mid-day trading, a decline of 38% from the average session volume of 1,565,494 shares. The stock had previously closed at $13.99.

The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.01. Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 25.28%. The firm had revenue of $113.28 million for the quarter, compared to analyst estimates of $112.33 million. During the same period in the previous year, the business earned $0.10 EPS. The company's revenue was up 18.4% compared to the same quarter last year. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Needham & Company LLC decreased their price objective on shares of Cellebrite DI from $24.00 to $18.00 and set a "buy" rating for the company in a research report on Thursday, August 14th. Lake Street Capital decreased their price objective on shares of Cellebrite DI from $24.00 to $22.00 and set a "buy" rating on the stock in a research note on Friday. Wall Street Zen raised Cellebrite DI from a "hold" rating to a "buy" rating in a report on Saturday. Finally, JPMorgan Chase & Co. cut their target price on Cellebrite DI from $29.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, May 12th. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Cellebrite DI has an average rating of "Buy" and an average target price of $22.40.

Institutional Investors Weigh In On Cellebrite DI

Several institutional investors and hedge funds have recently added to or reduced their stakes in CLBT. Signaturefd LLC grew its position in Cellebrite DI by 68.3% during the second quarter. Signaturefd LLC now owns 2,019 shares of the company's stock valued at $32,000 after buying an additional 819 shares during the period. Assetmark Inc. purchased a new stake in shares of Cellebrite DI during the 1st quarter valued at approximately $33,000. PNC Financial Services Group Inc. grew its stake in Cellebrite DI by 1,998.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,098 shares of the company's stock valued at $34,000 after buying an additional 1,998 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new stake in shares of Cellebrite DI during the first quarter worth $51,000. Finally, Virtus Advisers LLC bought a new position in shares of Cellebrite DI in the first quarter worth $63,000. Hedge funds and other institutional investors own 45.88% of the company's stock.

Cellebrite DI Stock Down 2.3%

The company has a market capitalization of $3.78 billion, a PE ratio of -20.84, a PEG ratio of 2.92 and a beta of 1.27. The company has a 50-day moving average price of $14.97 and a two-hundred day moving average price of $17.68.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.